Efficacy and Safety of Celecoxib in Chinese Patients with Ankylosing Spondylitis: A 6-Week Randomized, Double-Blinded Study with 6-Week Open-Label Extension Treatment

Background: Nonsteroidal anti-inflammatory drugs are the first-line option for treating ankylosing spondylitis (AS) in China. However, no large-scale controlled trials have been conducted in this ethnic population. Objective: To evaluate the efficacy and safety of 6 weeks’ treatment with celecoxib i...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Feng Huang, MD, Jieruo Gu, MD, Yi Liu, MD, Ping Zhu, MD, Yi Zheng, MD, Jin Fu, MD, Sharon Pan, PhD, Shi Le, MD
Format:	Artigo
Język:	Inglês
Wydane:	Elsevier 2014-12-01
Seria:	Current Therapeutic Research
Hasła przedmiotowe:	ankylosing spondylitis COX-2 inhibitors musculoskeletal system nonsteroidal anti-inflammatory drugs
Dostęp online:	http://www.sciencedirect.com/science/article/pii/S0011393X14000198
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!